Role of the L3T4+ T cell in allograft rejection
- PMID: 3121726
Role of the L3T4+ T cell in allograft rejection
Abstract
Pancreatic islet and fetal pancreas allotransplantation has been used to examine the role of the L3T4+ T cell in allograft rejection. Tissues were grafted into recipient animals depleted of peripheral L3T4+ T cells by in vivo administration of GK1.5 (anti-L3T4) monoclonal antibody to ask the question: is there a requirement for the L3T4+ T cell in graft rejection? Data show that the requirement for the L3T4+ T cell depends on either the type of tissue transplanted or type of the antigenic disparity between donor and recipient. Data also indicate that islet allograft acceptance achieved after GK1.5 treatment of the recipient is not due to tolerance induction. We therefore conclude that the cellular requirements for allograft rejection are determined by the type of tissue transplanted and the genetic disparity between donor and recipient.
Similar articles
-
Inhibition of transplant rejection by pretreatment of xenogeneic pancreatic islet cells with anti-ICAM-1 antibodies.Transplantation. 1994 Sep 27;58(6):681-9. Transplantation. 1994. PMID: 7940687
-
Effect of L3T4 and Lyt-2 monoclonal antibodies on islet xenograft (rat to mouse) rejection.Transplant Proc. 1989 Feb;21(1 Pt 3):2709-10. Transplant Proc. 1989. PMID: 2495677 No abstract available.
-
Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse.Diabetes. 2006 Jan;55(1):27-33. Diabetes. 2006. PMID: 16380473
-
Manipulation of pancreatic islet cells in allotransplantation.Transplant Proc. 1982 Dec;14(4):714-23. Transplant Proc. 1982. PMID: 6820204 Review. No abstract available.
-
Prevention of rejection by treatment of the graft: an overview.Prog Clin Biol Res. 1986;224:87-117. Prog Clin Biol Res. 1986. PMID: 2948196 Review.
Cited by
-
Recognizing Complexity of CD8 T Cells in Transplantation.Transplantation. 2024 Nov 1;108(11):2186-2196. doi: 10.1097/TP.0000000000005001. Epub 2024 Apr 19. Transplantation. 2024. PMID: 38637929 Review.
-
CD4 T cell-mediated cardiac allograft rejection requires donor but not host MHC class II.J Clin Invest. 2000 Oct;106(8):1003-10. doi: 10.1172/JCI10467. J Clin Invest. 2000. PMID: 11032860 Free PMC article.
-
Allograft rejection results from a failed attempt by the immune system to protect foreign tissue.Immunol Res. 2000;21(2-3):177-83. doi: 10.1385/ir:21:2-3:177. Immunol Res. 2000. PMID: 10852115 Review.
-
Increasing transplant mass results in long-term allograft survival and recovery from transplant vasculopathy.J Clin Immunol. 2003 May;23(3):162-74. doi: 10.1023/a:1023353711132. J Clin Immunol. 2003. PMID: 12797538
-
IL-4 expression delays eosinophil-independent vasculopathy and fibrosis during allograft rejection in the mouse.J Clin Immunol. 2003 Mar;23(2):119-31. doi: 10.1023/a:1022576828317. J Clin Immunol. 2003. PMID: 12757264
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical